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763TLQP-equires glutamate signaling to promotes early-ase neurogenesisNPCs indicating that these signaling molecules downstream of glutamate receptors are essential for the actions of TLQP-62 on
neurogenesis. We also show that TLQP-62 gradually activates Brain-Derived Neurotrophic Factor (BDNF)-receptor TrkB in vitro
and that Trk signaling is required for TLQP-62-induced proliferation of NPCs. Understanding the precise molecular mechanism
of how TLQP-62 influences neurogenesis may reveal mechanisms by which VGF-derived peptides act as antidepressant-like
agents.
© 2014 The Authors. Publishedby Elsevier B.V.This is an openaccess article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Clear evidence now exists that areas in the adult mammalian
brain contain pools of neural stem cells that generate new
neurons (Grote and Hannan, 2007; Manganas et al., 2007). In
the dentate gyrus of the hippocampus, these new neurons
mature, become synaptically integrated into the existing
circuitry, and contribute towards normal hippocampal func-
tion. Adult neurogenesis is comprised of three major process-
es: proliferation, differentiation and maturation. A multi-step
neurogenesis process in the dentate gyrus has been described
starting from slow-dividing radial glia-like stem/progenitor
cells (type-1) to fast-dividing glial-like, non-radial cells
(type 2a) to neuronal determined cells (type 2b) to neuronal
determined migratory cells (type 3) and finally to postmitotic
mature neurons (Filippov et al., 2003; Fukuda et al., 2003;
Kronenberg et al., 2003; Seri et al., 2004; Steiner et al., 2008).
There is evidence that excitatory neuronal activity affects
the proliferation of NPCs followed by neuron production and
integration of newly born cells into the neuronal network
(Deisseroth et al., 2004; Walker et al., 2008). For example,
long-term potentiation (LTP) has been shown to enhance
proliferation and survival of adult-generated neurons (Bruel-
Jungerman et al., 2006). It is known that the process of
neurogenesis is dynamic and can be regulated by different
physiological, pathological and pharmacological stimuli that
also regulate hippocampal synaptic activity. These stimuli
include exercise, enriched environments, antidepressants and
intrinsic factors (Dranovsky and Hen, 2006; Duman, 2005).
However, the specific mechanism by which some of these
factors induce neurogenesis is not known.
Intrinsic factors that induce neurogenesis include
neurotrophins and neuropeptides, which are released by
neuronal activity. Two specific factors, neuropeptide VGF
(non-acronymic) and Brain-Derived Neurotrophic Factor
(BDNF) have received attention in the context of their
contribution to either proliferation or survival of newly born
neurons. VGF is a neuronal peptide originally identified as an
NGF-responsive gene that is widely expressed in the brain and
is involved in maintaining energy balance (Ferri et al., 2011;
Levi et al., 2004). Vgf is an activity dependent gene and is
upregulated in the hippocampus by paradigms that reflect
increased activity such as learning (Alder et al., 2003), the
induction of LTP (Hevroni et al., 1998), seizures (Snyder et al.,
1998), electroconvulsive shock (ECS) (Altar et al., 2004;
Newton et al., 2003), voluntary exercise (Hunsberger et al.,
2007; Tong et al., 2001) and synaptogenesis (Benson and
Salton, 1996; Lombardo et al., 1995). Furthermore, tetrodo-
toxin (TTX) mediated blockade of retinal activity during the
critical period of visual development led to amarked decreasein Vgf mRNA levels in the visual cortex, demonstrating
that neuronal activity is essential for the induction of VGF
expression (Lombardo et al., 1995; Snyder et al., 1998).
We have previously demonstrated that VGF-derived
peptide TLQP-62, the C-terminal 62 amino acid peptide
enhances neurogenesis of hippocampal cells in vitro and in vivo
(Thakker-Varia et al., 2007). In support of the role of VGF in
neurogenesis, a megalencephalic mutant mouse has a two-fold
enlarged hippocampus as well as increased levels of VGF
(Almgren et al., 2008). Our studies have also established that
TLQP-62 enhances synaptic activity of hippocampal neurons
acutely in a manner very similar to BDNF and that TLQP-62 is
induced following a hippocampal-dependent learning paradigm
in rats (Alder et al., 2003). Others have shown that TLQP-62
potentiates synaptic transmission in hippocampal slices in a
BDNF-dependent manner (Bozdagi et al., 2008), thus suggesting
a close interaction between TLQP-62 and BDNF in themodulation
of hippocampal synaptic function. However, the ability of
TLQP-62 to regulate TrkB receptor activity and whether the
effect of TLQP-62 on synaptic activity is involved in the increase
in TLQP-62–induced neurogenesis has not been addressed.
In the present study we have focused on understanding
the role of TLQP-62 in the coupling of neurogenesis and
synaptic activity. To this end, we have ascertained the
precise stage at which the neural progenitor cells are
influenced by TLQP-62, and tested the requirement of
specific glutamatergic receptors implicated in synaptic activ-
ity for the proliferation induced by TLQP-62. In addition, we
have explored the downstream signaling pathways that are
responsible for TLQP-62-induced neurogenesis via glutamate
receptors. Our results also demonstrate that TLQP-62 induces
phosphorylation of the TrkB and that this activation appears to
be required for TLQP-62-induced proliferation of neural
progenitor cells. Revealing the precise molecular mechanism
of how TLQP-62 influences neurogenesis will increase our
understanding of the pathophysiological mechanisms underly-
ing disorders such as depression, epilepsy, stroke and
neurodegenerative diseases in which alterations in adult
neurogenesis or neuronal activity has been implicated. In
addition, TLQP-62 may represent a way to regulate stem cell
proliferation, which has therapeutic potential.Materials and methods
Peptide treatment in vivo
Nestin-GFP transgenic mice on a C57BL/6 background were
obtained from Dr. Grigori Enikopolov at Cold Spring Harbor, NY
(Mignone et al., 2004). Adult (3–4 month) male mice (~30 g)
764 S. Thakker-Varia et al.were used for in vivo experiments. Micewere implantedwith a
cannula in the lateral ventricle (Alzet Brain Infusion Kit 3,
DURECT Corporation, Cupertino, CA) as previously described
(Thakker-Varia et al., 2010). Coordinates were anterior–
posterior −0.1 mmwith respect to bregma; lateral, ±1.0 mm;
ventral, −3.0 mm with respect to the surface of the skull
(Bartolomucci et al., 2007). Cannulae were secured with
Loctite glue. An osmoticminipump (Alzet 2004, 0.25 μl/h) was
loaded with saline (4 mice) or TLQP-62 (4 mice) (TLQP-62
C-terminal amidated peptide, Biopeptide Co., San Diego, CA)
to deliver 15 μg/day intracerebroventricularly (ICV) for
28 days (Bartolomucci et al., 2007; Siuciak et al., 1997; Ullal et
al., 2007;Woodside et al., 2002), connected to the cannula and
implanted subcutaneously. A number of neuropeptides and
neurotrophins have been shown to be stable for several
weeks in the osmotic minipump (Hagg et al., 2005; Larsen et
al., 2000; Royo et al., 2006; Sahu, 2002; Shibayama et al.,
1998). Two weeks following implantation of cannula and
mini-osmotic pump, the mice were injected with 5-ethynyl-
2′-deoxyuridine (EdU) (50 mg/kg) (Invitrogen, Grand Island,
NY) and perfused with 4% paraformaldehyde (PFA) 2 h later.
Correct placement of the cannulae after ICV delivery of
TLQP-62 was verified following cryosectioning by visualizing
the track of the cannula into the lateral ventricle. Only animals
with the correct cannula placement were used for analysis.
Immunohistochemistry
Ten 40 μm sections from each brain were placed in cell
filters with PBS 0.5% Triton X100 and 3% BSA. They were then
incubated with the Click-iT reaction cocktail (Invitrogen,
Grand Island, NY) for 30 min. EdU followed by Click-iT
reaction has a clear advantage for tissue sections subjected
to multiple antibodies since a third antibody is not required.
For triple labeling of TLQP-62 treated mice sections were
blockedwith 5% Rabbit Serum, 1% BSA, and 0.5% Triton ×100 in
PBS. These sections were incubated with primary antibody
overnight at 4 °C containing goat polyclonal anti-DCX (1:100,
Santa Cruz, Santa Cruz, CA) and chicken polyclonal anti-GFP
(1:1000, Invitrogen, Grand Island, NY) in 0.1% Triton in PBS.
The sections were then treated with secondary antibody,
containing rabbit anti goat 594 (Invitrogen, Grand Island, NY)
and rabbit anti-chicken FITC (Millipore, Billerica, MA) at 1:250
in PBS for 2 h. Finally, the sections were incubated with
4′,6-diamidino-2-phenylindole (DAPI, Sigma, St. Louise, MO)
(1:1000). At least thirty cells from the left dentate gyrus of
each mouse were counted on a confocal microscope at 40×
and determined to be Type 2a (EdU+, Nestin+, DCX−), Type
2b (EdU+, Nestin+, DCX+) or Type 3 (EdU+, Nestin−, DCX+).
Culture of stem cell line derived from
adult hippocampus
Neural progenitor cells (NPCs) were kindly provided by
the Gage laboratory (Salk Institute). The stem cells were
originally isolated from the dentate gyrus of adult Fisher
344 rats. The expanded cultures from single clones were
infected with retrovirus to express GFP and selected as
previously described (Palmer et al., 1997). They were
propagated on poly-L-ornithine (10 μg/ml, Sigma, St. Louis,
MO) and laminin (5 μg/ml, Invitrogen, Grand Island, NY)coated plates (polyorn/lam) in Dulbecco's Modified Eagle
Medium (DMEM)/F12 medium high glucose (Omega Scientific,
Tarzana, CA) containing N2 supplement (Invitrogen, Grand
Island, NY), L-glutamine (2 mM), penicillin/streptomycin
(100 U/ml) and FGF-2 (20 ng/ml, PeproTech, Rocky Hill, NJ).
Cultures of GFP+ stem cells between passages 15 and 20 were
used in this study (Song et al., 2002).
Culture of primary adult hippocampal progenitor cells
P60 CD1 mice were used to isolate the subgranular zone of
the hippocampus using a protocol adapted from (Deleyrolle
and Reynolds, 2009; Johansson et al., 1999). Tissue was
dissociated with papain (20 U/ml), trypsin (1.3 mg/ml), DNAse
(0.28 mg/ml), hyaluronic acid (0.7 mg/ml) and kynurenic acid
(0.2 mg/ml) followed by mechanical trituration. The cells
were plated in growth medium consisting of DMEM/F12 with
EGF (20 ng/ml, Peprotech, Rocky Hill, NJ), FGF (20 ng/ml,
Peptrotech, Rocky Hill, NJ), 1% B27 (Invitrogen, Grand Island,
NY) and antibiotic/antimycotic. Neurospheres were observed
within the first week and the medium was changed every
3–4 days. Neurospheres were dissociated into single cells by
mechanical trituration and plated on poly-L-ornithine/laminin
coated 24 wells as described below.
Proliferation and differentiation studies
NPCs or primary adult hippocampal progenitor cells were
plated at 15,000 cells/cm2 on poly-L-ornithine/laminin
coated dishes in DMEM/F12 medium containing N2 supple-
ment as described above with the exclusion of FGF-2 and
EGF. In some experiments, NPCs at 15,000 cells/cm2 were
co-cultured on hippocampal primary neurons (10 days
in vitro) in serum-free co-culture medium containing
DMEM, N2 supplement, sodium pyruvate (1 mM), glucose
(0.2 M), L-glutamine (2 mM), ovalbumin (0.1%), and penn/
strep. NPCs cultured on polyorn/lam coated dishes or on
hippocampal cell dishes were treated with either vehicle,
TLQP-62 (3 μM), scrambled peptide PEHN-62 (3 μM) or KCl
(20 mM). The dose of TLQP-62 was selected based on our
previous in vitro studies (Thakker-Varia et al., 2007). For
proliferation studies, 3 days after plating, BrdU (10 μM,
Sigma, St. Louis, MO) or EdU (10 μM, Invitrogen, Grand
Island, NY) was added for 2 h followed by fixation with 4%
paraformaldehyde. For differentiation studies, the medium
and factors were replaced after 4 days and the cells were
fixed after 7 days.
Hippocampal neuronal cultures
E18 (embryonic day 18) hippocampi were obtained from
timed-pregnant Sprague Dawley rats (Charles River,
Wilmington, MA) killed by CO2 asphyxiation in accordance
with institutional guidelines for care and use of animals.
Pooled tissue from each litter was mechanically triturated in
Eagle's Minimum Essential Medium (MEM) with glucose and
7.5% fetal bovine serum and plated on poly-D-lysine-coated
petri dishes at 350,000 cells/35 mm dish. Cultures were
maintained in serum-free Neurobasal medium containing B27
(Invitrogen, Grand Island, NY) and glutamine (SFM) at 37 °C in
a 95% air/5% CO2 humidified incubator as previously described
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neurons.
Inhibitor treatments
Cells were pretreated with inhibitors for 30 min prior to the
addition of TLQP-62 (3 μM). Inhibitors used were as follows:
tetrodotoxin (TTX) (1 μM, Sigma, St. Louis, MO), AP5 (50 μM,
Sigma, St. Louis, MO), 2-Methyl-6-(phenylethynyl)pyridine
(MPEP) (100 μM, Sigma, St. Louis, MO) bicuculline (20 μM,
Sigma, St. Louis, MO), nifedipine (10 μM, Sigma, St. Louis,
MO), w-conotoxin GVIA (1 μM, Millipore, Billerica, MA),
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (20 μM, Sigma,
St. Louis, MO), KN-93 (5 μM, Sigma, St. Louis), GF109203x
(10 μM, Tocris Bioscience, Minneapolis, MN), and K252a
(200 nM, Millipore, Billerica, MA).
Immunocytochemistry
For the proliferation studies on NPCs, cells were blocked
with 30% goat serum in PBS/0.3% Triton X-100. Chicken
anti-GFP (1:1000. Invitrogen, Grand Island, NY) was applied
overnight at 4 °C followed by rabbit anti-chicken FITC
(1:500, Millipore, Billerica, MA) for 1 h. The cells were
then fixed again with 4% paraformaldehyde, treated for
30 min with 2 N HCl, followed by anti-BrdU (1:100, Becton
Dickinson, San Jose, CA) for 1 h and Alexa Fluor 594 goat
anti-mouse (1:1000, Invitrogen, Grand Island, NY) for 1 h.
EdU staining for primary adult hippocampal progenitor cells
followed the manufacturers recommended protocol for the
Click-It reaction (Invitrogen, Grand Island, NY) followed by
DAPI to label nuclei. For the differentiation studies, cells
were blocked in 2% goat serum in PBS/0.1% Triton X-100
followed by MAP2ab (1:1000, Sigma, St. Louis, MO) overnight
at 4 °C and Alexa Fluor 594 goat anti-mouse (1:1000) for 1 h.
The dishes were then coverslipped with Flouromount G
(Southern Biotech, Birmingham, AL) and examined using a
Zeiss Axiovert 200 M microscope at 40× magnification.
Approximately 200 GFP+ cells were counted on every
dish and the percent of those cells that also expressed
BrdU or MAP2 was quantified. The data for each set were
normalized to the control for the set. For receptor
expression, anti-TrkB (1:100, Santa Cruz Biotechnology,
Santa Cruz, CA), anti-NMDA (1:100), anti-GluR2/3 (1:100) and
anti-mGluR5 (1:500) from Millipore (Billerica, MA) were used
overnight at 4 °C followed by Alexa Fluor 594 goat anti-mouse
(1:1000).
Real time RT-PCR
NPCs were grown in N2 medium without bFGF and treated
with vehicle, TLQP-62 (3 μM) or scrambled peptide PHEN-62
(3 μM) for 3 days. Total RNA was isolated from NPCs using
Trizol Reagent according to the manufacturer's protocol
(Invitrogen, Grand Island, NY). RNA was subjected to RQ1
DNAse treatment (Promega, Grand Island, NY) and phenol
chloroform extraction to remove genomic DNA. 100 μl of
cDNA was prepared from 2 μg RNA using random primers
and Superscript II reverse transcriptase (Invitrogen, Grand
Island, NY). 25 μl PCR reactions were then carried out using
gene specific primers designed by Primer Express softwareand SYBR Green (Applied Biosystems 7000 Sequence Detec-
tion System, Foster City, CA). Duplicate wells were included
for each condition and primer pair. Primers to rodent
Cyclin D1 and D2 were selected using Primer Express
software (Applied Biosystems). Primers specific to the
housekeeping gene, glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) were used as an internal control. Data
analysis was performed according to the protocol provided
by Applied Biosystems.
Western blot
Hippocampal neurons were solubilized in RIPA buffer and
protein content determined using the BCA Protein Assay
Reagent Kit (Pierce, Rockford, IL). Forty micrograms of
protein was denatured with NuPAGE Sample Reducing Agent
(Invitrogen, Carlsbad, CA) followed by separation on a 10%
BisTris NuPAGE gel (Invitrogen, Carlsbad, CA) and transfer
to PVDF membrane. Membranes were probed with anti-
phospho-CaMKII (1:1000, Abcam, Cambridge, MA), anti-CaMKII
(1:10,000, Abcam, Cambridge, MA), anti-phospho-PKD (1:500,
Millipore, Billerica, MA) or anti-PKC mu (1:1,000, Abcam,
Cambridge, MA). Membranes were washed, followed by 1 h
incubation with donkey anti-rabbit or anti-mouse horseradish
peroxidase-conjugated IgG (1:5000, GE Healthcare, Pitts-
burgh, PA) at room temperature. Proteins were detected
using enhanced chemiluminescence (PerkinElmer, Waltham,
MA). Levels of the immunopositive bands were quantified
densitometrically using Quantity One V 4.2.1 software on a
GelDoc 2000 (BioRad, Hercules, CA) (Thakker-Varia et al.,
2001).
Phospho-Trk ELISA
An enzyme-linked immunosorbent assay (ELISA) method was
used to measure the level of phosphorylated Trk receptors
from primary neurons as described (Rantamaki et al., 2011).
After TLQP-62 and BDNF treatments, the medium was
removed and the cells were lysed with cold lysis buffer.
Following 30 min incubation on ice cell lysate was trans-
ferred to pre-coated (sc-11-R, 1:500, Santa Cruz Biotech-
nology, Santa Cruz, CA; O/N at 4 °C) and pre-blocked
(2% BSA/PBS-T; 2 h at room temperature) white 96-well
OptiplateTM (PerkinElmer) plates. The plates were incubated
overnight at 4 °C and the wells washed with PBS-T and
anti-phosphotyrosine antibody was added to the wells
(biotinylated PY20, AbD Serotec, Raleigh, NC 1:1000 in 2%
BSA/PBS-T; O/N at 4 °C). Following sequential washes and
HRP-coupled tertiary antibody incubations (Streptavidin-HRP,
1:10000 in 2% BSA/PBS-T; overnight at 4 °C) ECL substrate
(Pierce, Rockford, IL) was added to the wells and lumines-
cence measured after 5 min with Varioskan Flash (Thermo
Fisher Scientific, Pittsburgh, PA) plate reader.
Statistical analysis
Statview software was used for analysis of all data. Data were
analyzed using two-tailed Student t-test or ANOVA followed by
Fishers PLSD post hoc test for multiple comparisons. p b 0.05
is considered significant.
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Our earlier studies demonstrate that the neuropeptide
TLQP-62 enhances BrdU incorporation both in vitro and in
vivo into cells that eventually differentiate into neurons
(Thakker-Varia et al., 2007). However, the exact stage of
neurogenesis at which TLQP-62 acts is not known. We have
now taken advantage of a very precise staging scheme based
on marker expression (Steiner et al., 2008) to identify which
progenitor population is affected by TLQP-62. We employed
transgenic mice whose precursor cells in the hippocampus
are labeled with GFP driven by the Nestin promoter
(Nestin-GFP). The regulatory elements of the nestin gene
direct reporter gene expression to the neuroepithelium of
the embryo and to stem and progenitor cells of the adult
brain (Encinas et al., 2006). TLQP-62 peptide (15 μg/day) or
saline vehicle was infused intracerebroventricularly (ICV) for
2 weeks by mini-osmotic pump into adult Nestin-GFP
transgenic mice and the proliferating cells identified by an
EdU pulse. EdU is a thymidine analog, and EdU labeling and
detection is very sensitive and specific as it is based on
Click-iT (Invitrogen) chemistry, which does not require any
other manipulations used for BrdU labeling. Co-labeling of
cells with EdU and different stage-specific antibodies allowed
us to delineate the phases of neurogenesis influenced
by TLQP-62. EdU was co-localized with Nestin-GFP and
doublecortin (DCX). We quantitated the proportion of Type
2a (EdU+, Nestin+, DCX−), Type 2b (EdU+, Nestin+, DCX+),
and Type 3 (EdU+, Nestin−, DCX+) cells in the dentate gyrus
of the hippocampus (Figs. 1A and B). TLQP-62 infused mice
exhibited a significant increase in the proportion of cells
that are Type 2a and a decrease in the proportion of cells
that are Type 3 relative to the saline infused mice (Fig. 1C).
These data suggest that TLQP-62 promotes early phases of
neurogenesis when proliferation is occurring and inhibits
differentiation. This is similar to what has been reported
following antidepressant treatment and voluntary exerciseFigure 1 TLQP-62 promotes proportion of early rather than later
Nestin-GFP adult mice injected with EdU (50 mg/kg) for 2 h. Type 2
(green) and DCX-, and Type 2b neuron in SGZ indicated by arrow is E
the SGZ indicated by arrow is EdU+ (pink), Nestin− and DCX+ (red). C
Bars represent average percent ±SEM. Proportion of Type 2a NPCs
Proportion of EdU+ cells for Type 3 NPCs from TLQP-62-treated den
n = 30–35 EdU+ cells per brain, 4 brains per condition, *p b 0.05,(Boku et al., 2011; Encinas et al., 2006; Kronenberg et al.,
2003; Steiner et al., 2008).
To study the mechanism by which TLQP-62 enhances
proliferation in progenitor cells, we used an adult rodent
neural progenitor cell (NPC) line. NPCs have been shown
to retain stem cell phenotypes in vitro and behave
identically to endogenous NPCs when implanted into the
intact hippocampus (Palmer et al., 1997). NPCs labeled
with GFP, were grown either on a polyornithine/laminin
coated surface or on hippocampal cultures derived from
E18 rat embryos to mimic a more in vivo type of environment
(Alder et al., 2003; Song et al., 2002). To determine the effect
of TLQP-62 on proliferation, TLQP-62 (3 μM) was added to
the NPCs after mitogen withdrawal for 72 h followed by
BrdU (10 μM) for 2 h to label cells undergoing DNA
synthesis. KCl (20 mM) which directly stimulates synaptic
activity was used for comparison as a stimulant of synaptic
activity. All data were normalized to PBS vehicle. We
observed that TLQP-62 increases the number of NPCs that
are positive for BrdU both on a polyornithine/laminin
coated substrate (vehicle 34.85 ± 4.58, TLQP-62 51.03 ±
5.35, % BrdU+) as well as on a bed of hippocampal neurons
(vehicle 34.41 ± 5.39, TLQP-62 49.70 ± 7.04, % BrdU+) to
approximately the same degree. KCl, on the other hand had
no effect on the number of proliferating cells on either
substrate (Fig. 2B).
To assess if TLQP-62 affects the number of NPCs differen-
tiating into neurons, immunofluorescence of Microtubule
Associated Protein 2 (MAP2), which specifically labels den-
drites, was quantitated after 7 days of TLQP-62 or vehicle
treatment. TLQP-62 does not affect the NPCs that express the
differentiation marker MAP2 on polyornithine/laminin (vehi-
cle 37.39 ± 6.26% MAP2+, TLQP-62 42.53 ± 6.98% MAP2+) or
hippocampal neuronal substrate relative to control (vehicle
10.31 ± 1.89% MAP2+, TLQP-62 12.56 ± 2.53% MAP2+). KCl
treatment did enhance the number of MAP2 positive cells
on the polyornithin/laminin coated dishes but showed an
inhibitory trend on MAP2+ cells on a hippocampal bed
(Fig. 2E), perhaps due to excitotoxicity. Previous studies
have shown that KCl does not affect adult NPC progenyphase neural progenitors in vivo. A, Immunohistochemistry of
a neuron in the SGZ indicated by arrow is EdU+ (pink), Nestin+
dU+ (pink), Nestin+ (green) and DCX+ (red). B, Type 3 neuron in
, Quantitation of proportion of EdU+ cells for Types 2a, 2b and 3.
from TLQP-62-treated dentate gyri increases relative to Saline.
tate gyri is significantly lower relative to the saline condition,
t-test.
Figure 2 TLQP-62 enhances proliferation but not differentiation of neural progenitor cells in vitro and increases Cyclin D1 and D2
mRNA levels. A, Representative images of GFP-expressing NPCs grown on polyornithine/laminin (polyorn/lam) coated dishes treated
with vehicle or TLQP-62 (3 μM) for 3 days followed by BrdU (10 μM) for 2 h. Arrows represent double-labeled cells. B, Quantitation of
BrdU+/GFP+ NPCs grown on polyorn/lam or hippocampal neurons (hipp cells). KCl (20 mM) is used as a control. C, Quantitation of
EdU+/DAPI+ primary adult hippocampal progenitor cells grown on polyorn/lam. D, Representative images of GFP-expressing NPCs
grown on polyorn/lam coated dishes treated with vehicle or TLQP-62 (3 μM) for 7 days followed by MAP2 staining. Arrows represent
double-labeled cells. Scale bar for A and D = 30 μM. E, Quantitation of MAP2+/GFP + cells grown on polyorn/lam or hipp cells.
F, Quantitation of EdU+/DAPI + primary adult hippocampal progenitor cells grown on polyorn/lam. Bars represent average ± SEM
normalized to the vehicle control for each experiment (n = at least 200 cells/dish, 5,6 dishes/condition for NPCs and 8,9 wells/condition
for primary adult hippocampal progenitors). G, Average Cyclin D1 and D2 gene expression in NPCs treated with scrambled peptide
(PEHN-62) and TLQP-62 (3 μM) for 3 days. All samples were first normalized to GAPDH and then represented as an average ratio of vehicle
control ± SEM * (n = 3). *p b 0.05 relative to control, ANOVA Fishers PLSD.
767TLQP-equires glutamate signaling to promotes early-ase neurogenesisproliferation, survival, or apoptosis but rather promotes
neuronal differentiation (Deisseroth et al., 2004). Our findings
of an effect of KCl on MAP2-positive cells but not on BrdU
positive cells are consistent with the findings of these studies.Our in vitro results are also in parallel with the in vivo studies,
which indicates that TLQP-62 promotes proliferation and the
early phase of neurogenesis rather than the later differenti-
ating phase.
Figure 3 TLQP-62-induced proliferation requires Na+ channels, NMDA receptors and mGluR5. A, Representative images of NPCs in
vitro immunostained for AMPA receptor, NMDA receptor, and metabotropic glutamate receptor 5. Scale bar = 30 μM. B, NPCs grown
on polyornithine/laminin (polyorn/lam) coated dishes or hippocampal cells (hipp cells) were pretreated with TTX (1 μM), AP5
(50 μM), or MPEP (100 μM) for 30 min prior to the addition of TLQP-62 (3 μM). After 3 days, cells were treated with BrdU (10 μM) for
2 h followed by fixation and immunocytochemistry for GFP and BrdU. Bars represent average number BrdU+/GFP+ cells normalized to
the vehicle control for each experiment ±SEM (n = 9–12 dishes/condition, 200 cells/dish). *p b 0.05 relative to control, * with
bracket represents significant difference between TLQP-62 and TLQP-62 plus inhibitor, ANOVA Fishers PLSD.
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cells, adult hippocampal progenitor cells were acutely isolated
from mouse dentate gyrus and grown in vitro. Cells were
initially grown as neurospheres and then dissociated and plated
on polyornithine/laminin coated wells to assess proliferation.
TLQP-62 treatment (3 μM) for 3 days had a robust effect
on proliferation of those progenitor cells relative to vehicle
control or a scrambled control peptide (PEHN-62) as shown by
EdU (10 μM) incorporation for 2 h (vehicle 2.25 ± 0.44% BrdU+,
PEHN-62 3.73 ± 0.82, TLQP-62 15.08 ± 2.14% BrdU+). Similar
to the NPC line, primary adult hippocampal progenitor cells
did not increase proliferation in response to KCl (Fig. 2C).
Moreover, there was no increase in MAP2+ cells when the
primary hippocampal progenitor cells were treated TLQP-62 or
PEHN-62 for 7 days (vehicle 21.29 ± 3.64% MAP2+, PEHN-62
22.77 ± 4.60% MAP2+, TLQP-62 20.78 ± 3.62% MAP2+) al-
though primary neural progenitor cells did show increased
MAP2 expression in response to KCl (Fig. 2F). These findings
support the conclusion that TLQP-62 promotes proliferation
but not differentiation of hippocampal progenitor cells isolated
from the adult hippocampus.
The effect of TLQP-62 on cyclin gene expression was
examined to further explore the role of the neuropeptide in
proliferation. NPCs were treated for 3 days with TLQP-62 or
scrambled control peptide PEHN-62 and subjected to real
time RT-PCR for Cyclin D1 and D2. D-type cyclins control
the transition from G1 to S (Sherr, 1994). They become
synthesized in response to mitogens and their expression
rapidly declines when mitogens are withdrawn (Matsushimeet al., 1994). The levels of Cyclin D1 and D2mRNA were both
increased in TLQP-62 treated NPCs when compared to
cells treated with the scrambled peptide PEHN-62 or vehicle
(Fig. 2G). Thus TLQP-62 appears to enhance the expression
of genes, which regulate the transition from G1 to S phase
and promote proliferation.Requirement for synaptic activity in
TLQP-62-induced neurogenesis
We have previously shown that TLQP-62 enhances synaptic
activity (Alder et al., 2003). However, the requirement of
activity for the effects of TLQP-62 on neurogenesis has not
been studied. To examine this question, NPCs were grown in
vitro in the presence of TLQP-62 plus selected pharmaco-
logical agents. It has been demonstrated that brief excita-
tion applied to actively proliferating NPCs is sufficient
for excitation-neurogenesis coupling. Furthermore, NPCs
do express Na+ channels and KCl-induced neurogenesis has
been shown to be blocked by TTX (Deisseroth et al., 2004).
To confirm that the NPCs express neurotransmitter recep-
tors, immunocytochemistry was performed and we con-
firmed that all the cells expressed AMPA, NMDA and mGluR5
receptors (Fig. 3A). To determine if TLQP-62 requires
activity to induce neurogenesis, cultures were pretreated
with inhibitors for 30 min prior to TLQP-62 exposure. The
following specific antagonists were used: Na+ channel (TTX,
1 μM), Ca2+ channel (Nifedipine, 10 μM), NMDA receptor (AP5,
769TLQP-equires glutamate signaling to promotes early-ase neurogenesis50 μM), AMPA receptor (CNQX, 1 nmol/0.5 μl), metabotro-
pic glutamate receptor (MPEP, 1 mM), GABAA receptor
(bicuculline, 10 μM). TLQP-62 significantly increased the
number of BrdU+ cells relative to vehicle. Our results
indicate that the inhibitors alone had no significant effect
on the number of BrdU+ cells except for TTX on a bed of
hippocampal neurons. However, pretreatment of NPCs
with TTX, AP5 and MPEP prior to addition of TLQP-62 all
significantly reduced the number of BrdU+ NPCs relative to
TLQP-62 alone (Fig. 3B). This suggests that NMDA receptors
and mGluR5 are required for TLQP-62 induced neurogenesis.
Several other synaptic activity inhibitors including the L-type
voltage dependent Ca2+ channel antagonist nifedipine, the
N-type Ca2+ channel antagonist w-conotoxin, the GABA
receptor antagonist bicuculline, and the AMPA/kainate
receptor inhibitor CNQX had no effect on TLQP-62-induced
proliferation (Supp Fig. 1), indicating that these molecules
are not involved in TLQP-62-induced neurogenesis.Signaling pathways downstream of
TLQP-62-induced neurogenesis
We have explored the downstream signaling events activat-
ed by TLQP-62 to mediate its actions on neurogenesis. We
first determined if TLQP-62 activates signaling molecules
in hippocampal cells downstream of the two glutamateFigure 4 TLQP-62 activates CaMKII via NMDAR and PKD via mGl
(10 div) that had been pretreated with AP5 (50 μM) or vehicle for 30
run on a 10% BisTris gel and the membrane probed for phospho-CaM
CaMKII phosphorylation. Bars represent average protein expression r
of hippocampal cultures (10 div) that had been pretreated with MPE
15 min. Protein lysates were run on a 10% BisTris gel and the mem
loading control. D, Quantitation of PKD phosphorylation. Bars repres
*p b 0.05 relative to control, * with bracket represents significant d
Fishers PLSD.receptors implicated in TLQP-62-induced proliferation, NMDA
and mGluR5. CaMKII can associate with NMDA receptors and
ultimately sustain its activation state (Bayer et al., 2001).
Moreover, activation of mGluR5 induces phosphorylation of
protein kinase D (PKD) in hippocampal neurons (Krueger et al.,
2010). Western blot analysis was performed on hippocampal
cells pretreated with an antagonist to NMDA receptors, AP5
(50 μM) or an antagonist tomGluR5, MPEP (100 μM) for 30 min
prior to addition of TLQP-62 (3 μM) for 15 min. Activation of
CaMKII and PKD was examined using phospho-specific anti-
bodies. Quantitation of the Western blots indicates that
TLQP-62 enhances phosphorylation of CaMKII and that this
activation can be blocked by AP5, suggesting that CaMKII is a
downstream target of NMDA receptors activated by TLQP-62
(Fig. 4). Similarly, we have demonstrated that TLQP-62
increases phosphorylation of PKD relative to control and
that this activation can be significantly reduced by the
mGluR5 receptor antagonist, indicating that PKD is down-
stream of mGluR5 receptors activated by TLQP-62 (Fig. 4).
The inhibitors alone had no significant effect on phosphor-
ylation of the kinases.
To further determine the role of these signaling pathways
in TLQP-62-induced neurogenesis, we used inhibitors to CaMKII
and PKD. Previous research demonstrated KN-93's potential to
inhibit CaMKII, preventing glutamate-induced miniature ex-
citatory postsynaptic currents, a process rescued through the
application of additional CaMKII (Ninan and Arancio, 2004).uR5. A, Representative Western blot of hippocampal cultures
min followed by TLQP-62 (3 μM) for 15 min. Protein lysates were
KII followed by CaMKII for a loading control. B, Quantitation of
elative to control ± SEM (n = 3). C, Representative Western blot
P (100 μM) or vehicle for 30 min followed by TLQP-62 (3 μM) for
brane probed for phospho-PKD followed by PKC mu (PKD) for a
ent average protein expression relative to control ± SEM (n = 3).
ifference between TLQP-62 and TLQP-62 plus inhibitor, ANOVA
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of PKD in primary cells (Jadali and Ghazizadeh, 2010; Van Lint
et al., 1998). NPCs were pretreated for 30 min with either
KN93 (5 μM) to prevent CaMKII activation or with GF109203x
(10 μM) to inhibit PKD activation. TLQP-62 (3 μM) when then
added to these NPCs for 72 h followed by addition of BrdU
(10 μM) for 2 h. Our data indicate that the TLQP-62-induced
increase in BrdU+ cells is significantly prevented by treatment
with either KN93 or GF109203x (Fig. 5). The inhibitors alone
did not have any effect on cell proliferation as indicated by the
number of BrdU+ cells. The finding that TLQP-62 no longer
enhances neurogenesis in the presence of those pharmacolog-
ical agents that inhibit CaMKII and PKD suggests that signaling
through glutamate receptors via CaMKII and PKD is required
for the effects of TLQP-62 on neurogenesis.
Role of BDNF signaling in
TLQP-62-induced neurogenesis
Previous studies suggest that TLQP-62 effects on synaptic
plasticity requires TrkB activation and may promote BDNF
release (Bozdagi et al., 2008). Although two receptors for
TLQP-21, both of which are complement receptors, have
recently been described (Chen et al., 2013; Hannedouche et
al., 2013), the receptor for TLQP-62 has not yet been
identified. We therefore began to explore the interaction
between TLQP-62-induced neurogenesis and TrkB. We first
demonstrated that TrkB is expressed on all NPCs (Fig. 6A). To
determine whether Trk is required for the effect of TLQP-62
on proliferation of NPCs, we used the K252a (200nM), a
broad-spectrum kinase inhibitor commonly used to block
BDNF-induced Trk phosphorylation. Pretreatment with K252a
alone for 30 min had no effect on BrdU incorporation.
However, NPCs pretreated with K252a followed by TLQP-62
(3 μM) for 3 days had significantly reduced incorporation ofFigure 5 TLQP-62-induced proliferation requires CaMKII and PKD.
A, KN-93 (5 μM), or B, GF109203x (10 μM) for 30 min prior to the ad
BrdU (10 μM) for 2 h followed by fixation and immunocytochemistry
cells normalized to the vehicle control for each experiment ±SEM
control, ANOVA Fishers PLSD.BrdU relative to cells treated with TLQP-62 alone (Fig. 6B).
These data suggest that Trk receptors are helping to
mediate the actions of TLQP-62. To determine the mecha-
nism by which TLQP-62 interacts with Trk receptors, we
quantitated TrkB phosphorylation by TLQP-62 using an ELISA
approach (Rantamaki et al., 2011). Primary neurons treated
with TLQP-62 (3 μM) for either 2 or 6 h did not show induction
of TrkB activation. However, cells treated with TLQP-62 for
24 h exhibited significantly higher TrkB phosphorylation
relative to vehicle-treated control cells. Cells treated with a
higher concentration of TLQP-62 (6 μM) for 2 h also showed a
significant increase in TrkB activation relative to vehicle
(control 100.00 ± 2.53, TLQP-62 111.80 ± 3.30 fold induction,
n = 20, p b 0.05, t-test). As a positive control, cells were
treated with BDNF (5 ng/ml) and TrkB phosphorylation was
detected within 15 min. TLQP-62 treatment (3 μM) for less
than 2 h did not show any induction of phospho-TrkB (data not
shown). These findings demonstrate that the effect of
TLQP-62 on TrkB requires an extended period of time relative
to BDNF and suggest that the effect of TLQP-62 on TrkB
phosphorylation is much less robust than that of BDNF.
Discussion
This study demonstrates that the neuropeptide TLQP-62
enhances the generation of early progenitor cells in the
dentate gyrus and that mGluR5 and NMDA receptors are
required for TLQP-62-induced proliferation of NPCs. The
signaling cascades activated by TLQP-62 downstream of the
glutamate receptors include PKD and CaMKII, which are
necessary for TLQP-62-mediated proliferation of NPCs. We
also investigated the relationship between TLQP-62 and
BDNF signaling and demonstrate not only that TLQP-62
promotes TrkB phosphorylation but also that Trk activation
is required for TLQP-62-induced proliferation of NPCs.NPCs grown on polyorn/lam coated dishes were pretreated with
dition of TLQP-62 (3 μM). After 3 days, cells were treated with
for GFP and BrdU. Bars represent average number BrdU+/GFP+
(n = 9 dishes/condition, 200 cells/dish). *p b 0.05 relative to
Figure 6 Trk is required for TLQP-62-induced proliferation of neural progenitor cells in vitro. A, Representative image of NPCs in
vitro immunostained for TrkB receptor. B, NPCs grown on polyorn/lam coated dishes were pretreated with K252A (200nM) followed by
BrdU (10 μM) for 2 h. Bars represent average number BrdU+/GFP+ cells normalized to the vehicle control for each experiment ±SEM
(n = 200 cells/dish, 9–12 dishes/condition). *p b 0.05 relative to control, * with bracket represents significant difference between
TLQP-62 and TLQP-62 plus inhibitor, ANOVA Fishers PLSD. C, Neurons (21 div) were treated with TLQP-62 (3 μM) or BDNF (5 ng/ml) for
various times indicated and TrkB phosphorylation measured by phosphor-TrkB ELISA. Data is presented as percentage of control ± SEM
(n = 5–18). *p b 0.05 relative to control t-test.
771TLQP-equires glutamate signaling to promotes early-ase neurogenesisTogether these findings lend insight into how TLQP-62
modulate adult hippocampal neurogenesis and may suggest a
mechanism for the antidepressant-like effects of VGF-derived
peptides that we and others have reported (Hunsberger et al.,
2007; Thakker-Varia et al., 2007, 2010).
Neurogenesis in the adult rodent hippocampus is a highly
systematic process involving proliferation, differentiation, and
migration that is controlled by various factors (Palmer et al.,
1997). New granule cell neurons arise from the neural
progenitors of the subgranular zone of the dentate gyrus
(Song et al., 2002) and many factors including both intracel-
lular and extracellular contribute towards the different stages
of neurogenesis. Trophic factors such as FGF-2 (Zhao et al.,
2007) and NT-3 (Shimazu et al., 2006) alongwith growth factors
such as IGF-1 (Aberg et al., 2000) and VEGF (Jin et al., 2002)
have been shown to have an effect on different phases of
neurogenesis in the dentate gyrus. We have previously shown
that neuropeptide TLQP-62 increases adult neurogenesis
(Thakker-Varia et al., 2007) and in this study using markers of
different stages of proliferation we have deciphered the exact
stage of neuronal development at which TLQP-62 has the most
effect. Specifically, TLQP-62 increases the number of Type 2a
(undetermined) cells. Different neurogenic stimuli have been
shown to affect the dividing cells at different stages of
neuronal development. Type 1 cells are the stem cells and
generally do not respond to many stimuli. On the other hand
Type 2 cells do respond to chemical stimuli such as antidepres-
sants, as well as physiologic activities such as environmental
enrichment and exercise (Kronenberg et al., 2003).
The effects of TLQP-62 on neurogenesis are thus similar to
what is reported for antidepressant fluoxetine and serotonin
(5-HT), both of which increase the proportion of undetermined
Type 2a NPCs marked by Nestin+ and DCX-immunostaining and
lacking the radial glial-like morphology (Boku et al., 2011;
Encinas et al., 2006). The effect of TLQP-62 is also similar to
the effect of exercise, which stimulates the division of both
Type 2a and Type 2b cells (Kronenberg et al., 2003; Steiner et
al., 2008). These findings support our theory that VGF-derivedpeptides affect a specific neurogenesis pathway and act as
antidepressant-like agents (Hunsberger et al., 2007; Thakker-
Varia et al., 2010) since both fluoxetine and exercise promote
neurogenesis and have antidepressant-like actions (Engesser-
Cesar et al., 2007; Huang et al., 2012). In contrast, kainic acid,
a compound that induces seizures and subsequently results in
aberrant neurogenesis, but does not have antidepressant-like
activity, is known to promote Type 3 (determined migratory)
NPCs over the earlier stages in its differentiation pathway
(Jessberger et al., 2005; Steiner et al., 2008). Thus, our
results suggest that VGF-derived peptides, which are known to
have antidepressant effects in animal models (Hunsberger
et al., 2007; Thakker-Varia et al., 2007, 2010), have a
similar mechanism in promoting neurogenesis as “classical”
antidepressants.
In this study, the mechanism of TLQP-62-induced prolif-
eration was dissected using NPCs in vitro. We detected
equivalent increased proliferation of NPCs by TLQP-62 on
both coated plates as well as a bed of hippocampal cultures
suggesting that the effect of TLQP-62 on NPC proliferation is
cell autonomous and does not require factors provided by
other cells in the hippocampus. In contrast, there was no
significant effect of TLQP-62 on differentiation of NPCs on
either type of substrate, consistent with the in vivo data that
TLQP-62 promotes early phases of neurogenesis rather than
differentiation and indicating that non-cell autonomous
factors are not sufficient to induce differentiation by
TLQP-62. The positive control, KCl, was expected to signifi-
cantly enhance differentiation relative to the untreated
controls (Deisseroth et al., 2004), which it only did on the
polyornithine plus laminin coated dishes. It is believed that
KCl failed to enhance differentiation when NPCs were plated
on a bed of hippocampal neurons in our study because the
prolonged exposure to KCl could have had excitotoxic effects
on the mature hippocampal neurons which in turn may have
affected the health of the NPCs.
Primary adult hippocampal neural progenitor cells were
used to demonstrate that the effects of TLQP-62 are not
772 S. Thakker-Varia et al.specific to stem cell lines. We observed a robust effect of
TLQP-62 on proliferation of primary adult hippocampal
progenitors. The primary cells, once dissociated from the
neurospheres and plated on a coated substrate in the
absence of FGF, show a reduced baseline proliferation
relative to the stem cell line. The plated cells are perhaps
very sensitive and responsive to growth factors which likely
explains the higher fold effect of TLQP-62 in the primary
cells relative to the cell line. The studies using TLQP-62
peptide in this study are gain-of-function experiments which
could cause a pharmacologic peptide response. To address
this possibility, scrambled peptide with the same amino acid
composition of TLQP-62, PEHN-62, was used as a control and
we observed no response of the cells to the scrambled
peptide suggesting that the effects are specific to TLQP-62.
Future experiments using TLQP-62 knockdown approaches
will confirm the effects are specific to TLQP-62.
To further delineate the role of TLQP-62 in proliferation,
we examined the cell cycle status of the cells treated with
the neuropeptide. D-type cyclins control the transition from
G1 to S (Sherr, 1994). D-type cyclins are thought to be a
molecular link between the extracellular environment and
the cell cycle machinery since they are synthesized in
response to mitogens and their expression rapidly declines
when mitogens are withdrawn (Matsushime et al., 1994).
D-type cyclins have been shown to be regulated by other
neuropeptides that affect proliferation in normal as well as
neoplastic cells in the body (de Mendonca et al., 2013;
Fernandez-Martinez et al., 2009; Song et al., 2003). In the
nervous system, neuropeptides such as pituitary adenylate
cyclase-activating polypeptide (PACAP) and extracellular
signaling molecule, Wnt7a stimulate Cyclin D expression and
regulate cerebral cortical proliferation (Qu et al., 2013; Yan
et al., 2013). Moreover, Cyclin D2 knockout mice have
impaired adult hippocampal neurogenesis (Ansorg et al.,
2012; Kowalczyk et al., 2004) whereas overexpression of
Cyclin D1 causes an expansion of the neural progenitor cells
in the adult mouse hippocampus (Artegiani et al., 2011). Our
data demonstrate that cyclin D1 and D2 mRNA levels are
upregulated in response to TLQP-62 treatment of NPCs but
that scrambled control peptide PEHN-62 has no effect on
cyclin D expression. Thus one mechanism by which TLQP-62
regulates neurogenesis may be by altering the expression of
proteins which control the cell cycle machinery.
We now demonstrate that TLQP-62-enhanced synaptic
activity (Alder et al., 2003; Bozdagi et al., 2008) is required
for the effect of the neuropeptide on neurogenesis of NPCs. Our
findings are consistent with studies which found that electrical
excitation drives NPC neurogenesis in the adult hippocampus
(Bruel-Jungerman et al., 2006; Deisseroth et al., 2004; Walker
et al., 2008). The inhibition of TLQP-62-induced proliferation
by TTX is supported by the fact that NPCs possess K+ and Na+
channels (Leng et al., 2009;Mistry et al., 2002). However, while
KCl promotes neurogenesis in a Ca2+-dependent manner
(Deisseroth et al., 2004), TLQP-62 does not require Ca2+
channel activation. The difference in findings may relate
to the fact that TLQP-62 promotes proliferation while KCl
enhances the differentiation phase of neurogenesis.
The presence of neurotransmitter receptors in NPCs
including GABA, AMPA and NMDA receptors has also been
documented by expression analysis (Kitayama et al., 2004)
as well as electrophysiological studies in the presence ofpharmacological agents (Mistry et al., 2002). The specific
receptors we identified as required for TLQP-62-induced
neurogenesis include mGluR5 and NMDA, consistent with
reports demonstrating the role of glutamate receptors in
neurogenesis. A recent study demonstrates that mGluR5
mutant mice have reduced numbers of cells expressing
markers of proliferation and differentiation (Xiao et al.,
2013) and that antagonists to metabotropic glutamate
receptors inhibit neurogenesis in vivo (Baskys et al., 2005;
Xiao et al., 2013). Together these studies suggest a positive
role for mGluR5 in neurogenesis although opposite results
have been reported for Group II metabotropic receptors
(Feng et al., 2011; Yoshimizu and Chaki, 2004).
The role of the NMDA receptor in promoting neurogenesis
has also been documented. Treatment of NPCs with NMDA
increased the number of proliferating cells in the adult dentate
gyrus (Joo et al., 2007). Furthermore, the regulation of NMDA
receptor expression is positively correlated with neurogenesis
and vice versa (Kalev-Zylinska et al., 2009; Marx et al., 2011;
Ren et al., 2013; Sharma et al., 2012). Moreover, NMDA
receptor activation is required for both basal neurogenesis and
enhanced neurogenesis of NPCs elicited by KCl (Deisseroth et
al., 2004) and downregulation of NMDA receptor expression
mediates impaired neurogenesis in the hippocampus of
knockout mouse models (Sha et al., 2013). Finally, NMDA
subunit receptor deletion from adult-born neurons impairs a
neurogenesis-dependent form of LTP (Kheirbek et al., 2012).
While all of these studies suggest a positive role of NMDA in
promoting neurogenesis, other studies have shown that NMDA
receptor activation inhibits neurogenesis (Cameron et al.,
1995; Nacher et al., 2001), however these effects may depend
on NMDA concentration, age of cells and stage of development.
Our data suggest that PKD phosphorylation is a key
downstream event after TLQP-62-induced activation of
mGluR5 receptors in NPCs. Our data also suggest that this
kinase is required for TLQP-62-induced proliferation of NPCs.
These findings are supported by a study, which shows that
activation of mGluR5 induces phosphorylation of PKD in
hippocampal neurons (Krueger et al., 2010). PKD, which is a
serine threonine kinase is considered to belong to the Ca2+/
calmodulin dependent kinase superfamily (Valverde et al.,
1994). PKD has been implicated in promoting DNA synthesis
and cell proliferation in several cellular systems and is
involved in vascular endothelial growth factor (VEGF) medi-
ated proliferation (Wong and Jin, 2005). Consistent with PKD's
promotion of proliferation, the kinase also has anti-apoptoic
properties in tumor cells (Trauzold et al., 2003). Similarly, in
addition to its effect on proliferation, VGF has been shown to
have anti-apoptotic activity. A shorter VGF peptide, TLQP-21,
was shown to prevent cerebellar granule cell death induced by
serum and potassium deprivation suggesting a trophic-like
activity for VGF. The effect of TLQP-21 in survival of
cerebellar granule cells required PKC activation (Severini
et al., 2008) suggesting that the same VGF signaling
mechanisms may promote proliferation and prevent apoptosis.
Transcriptional changes regulated downstream of TLQP-62's
activation of mGluR5 via PKD involved in proliferation and
survival remain to be elucidated.
We identified CaMKII as a downstream target of NMDA
receptors activated in NPCs following TLQP-62 treatment.
CaMKII can associate with NMDA receptors and ultimately
sustain its activation state (Bayer et al., 2001). Supporting
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study showing that mouse mutants for CaMKII have impair-
ments in maturation of granule cells in the dentate gyrus
(Yamasaki et al., 2008). A recent study demonstrates that
olfactory bulbectomized mice treated with a steroid receptor
agonist that activates CaMKII have increased neurogenesis as
well as LTP (Moriguchi et al., 2013). The mechanism by which
CaMKII induces TLQP-62-mediated proliferation following
NMDA receptor activation has yet to be explored.
Recently, two receptors for TLQP-21 have been described
(Chen et al., 2013; Hannedouche et al., 2013). Both of these
receptors C3aR1 and gC1qR are complement receptors and are
thought to be involved in the role of TLQP-21 in neuropathic
pain (Chen et al., 2013) and metabolism (Hannedouche et al.,
2013). It has not yet been tested whether TLQP-62 binds
to either of these receptors or whether they are expressed in
the hippocampus. In this study, we explored the possible
interactions between TLQP-62 with glutamate receptors as
well as the BDNF receptor to yield novel insights into the
signaling pathways of TLQP-62. We found that TLQP-62
requires activation of Trk receptors to mediate its effect on
neurogenesis. Moreover, TLQP-62 induces phosphorylation of
TrkB, albeit with a slower time course and to a lesser extent
than BDNF. This suggests that TLQP-62 may not activate TrkB
directly, but is perhaps inducing the release of BDNF, which in
turn is binding to its receptor TrkB and promoting glutamate
release. Alternatively, TLQP-62 could transactivate TrkB
independently of BDNF as previously shown for adenosine
and PACAP (pituitary adenylate cyclase-activating polypep-
tide) (Lee and Chao, 2001; Lee et al., 2002a,b). Our findings
are supported by a previous study, which suggests that TrkB
may be downstream of the effect of TLQP-62 on synaptic
activity. Specifically, the transient potentiation of activity by
TLQP-62 peptide could be blocked by the BDNF scavenger
TrkB-Fc, the Trk tyrosine kinase inhibitor K252a and the tPA
inhibitor tPA STOP (Bozdagi et al., 2008).
The role of BDNF and its receptor TrkB in neurogenesis
has been explored. Overexpression or infusion of BDNF in the
adult rat results in newly generated cells (Benraiss et al.,
2001; Pencea et al., 2001; Scharfman et al., 2005) and BDNF
is required for enhancement of hippocampal neurogenesis
(Lee et al., 2002a,b; Rossi et al., 2006). Although some
studies suggest that BDNF promotes the survival rather than
proliferation or differentiation of new neurons (Bath et al.,
2008; Sairanen et al., 2005), TrkB deletion specifically in
progenitor cells of the dentate gyrus results in impaired
neurogenesis induced by antidepressant treatment, suggest-
ing that proliferation of progenitor cells is mediated by TrkB
signaling. Deletion of TrkB in differentiated cells of the
dentate gyrus, on the other hand, had no effect on the
number of neurons (Li et al., 2008). A possible explanation
as to why some studies have found that BDNF affects
proliferation (Li et al., 2008) while others have found it to
only affect survival (Sairanen et al., 2005) is the use
of different promoters to delete TrkB affected different
cell populations (Banasr and Duman, 2008). Our studies
suggest that TrkB may be playing a role in TLQP-62-induced
proliferation of NPCs.
We have previously shown that TLQP-62 expression is
induced by factors that have antidepressant activity. Con-
versely, VGF is downregulated in rodent models of depression
(Thakker-Varia et al., 2007). Along with others, we havedemonstrated that infusion of VGF-derived peptides in the
hippocampus of mice results in antidepressant-like outcomes
(Hunsberger et al., 2007; Thakker-Varia et al., 2010). We have
also shown that VGF is downregulated in human bipolar
disorder and acts as a mood stabilizer in models of mania.
Moreover, VGF levels are downregulated in leukocytes of
depressed patients but are restored in response to antide-
pressant treatment (Cattaneo et al., 2010). BDNF has also
been implicated in depression (Castren et al., 2007; Duman
and Monteggia, 2006). Antidepressant agents activate TrkB
(Rantamaki et al., 2007) and local infusion of BDNF or
overexpression of TrkB receptor in the brain mimics antide-
pressant effects in animal models (Koponen et al., 2005;
Shirayama et al., 2002; Siuciak et al., 1997). On the other
hand, BDNF signaling is essential for the behavioral effects of
the drugs (Monteggia et al., 2004; Saarelainen et al., 2003).
Thus, decreased levels of VGF and BDNF contribute to
depression and increased levels via antidepressant treat-
ment result in enhanced neurogenesis in the hippocampus.
Our data showing activation of TrkB by VGF-derived peptide
TLQP-62 support a possible link between neuropeptides and
neurotrophins in antidepressant actions.
The ultimate identification of the TLQP-62 receptor and
other interacting proteins will reveal the other players
involved in TLQP-62-mediated neurogenesis and give addi-
tional insight into the role that synaptic activity has on that
process. Stem cells in the hippocampus have been suggested
to have roles in learning and memory as well as psychiatric
disorders. Thus understanding which external factors influ-
ence the production and differentiation of new neurons in
the dentate gyrus and the mechanism of their action is
critical for future studies which may manipulate this stem
cell population for therapeutic purposes.
Supplementary data to this article can be found online at
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